$2500 | Single User
$5000 | Site License
$7500 | Enterprise License

Lysosomal Storage Disorder Global Clinical Trials Review, H2, 2015
[Lowest Price Guaranteed: $2,500]

Published by Global Data: 23 Dec 2015 | 17905 | In Stock
Related Topics: Clinical Trials

Introduction

Lysosomal Storage Disorder Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Lysosomal Storage Disorder Global Clinical Trials Review, H2, 2015" provides an overview of Lysosomal Storage Disorder clinical trials scenario. This report provides top line data relating to the clinical trials on Lysosomal Storage Disorder. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
for Lysosomal Storage Disorder Global Clinical Trials Review, H2, 2015

  • Table of Contents

    Table of Contents 2

    List of Tables 3

    List of Figures 4

    Report Guidance 5

    Clinical Trials by Region 6

    Clinical Trials and Average Enrollment by Country 7

    Top Countries Contributing to Clinical Trials in Asia-Pacific 10

    Top Five Countries Contributing to Clinical Trials in Europe 11

    Top Countries Contributing to Clinical Trials in North America 12

    Top Countries Contributing to Clinical Trials in Middle East and Africa 13

    Top Countries Contributing to Clinical Trials in Central and South America 14

    Clinical Trials by G7 Countries: Proportion of Lysosomal Storage Disorder to Metabolic Disorders Clinical Trials 15

    Clinical Trials by Phase in G7 Countries 16

    Clinical Trials in G7 Countries by Trial Status 17

    Clinical Trials by E7 Countries: Proportion of Lysosomal Storage Disorder to Metabolic Disorders Clinical Trials 18

    Clinical Trials by Phase in E7 Countries 19

    Clinical Trials in E7 Countries by Trial Status 20

    Clinical Trials by Phase 21

    In Progress Trials by Phase 22

    Clinical Trials by Trial Status 23

    Clinical Trials by End Point Status 24

    Subjects Recruited Over a Period of Time 25

    Clinical Trials by Sponsor Type 26

    Prominent Sponsors 27

    Top Companies Participating in Lysosomal Storage Disorder Therapeutics Clinical Trials 28

    Prominent Drugs 30

    Clinical Trial Profile Snapshots 31

    Appendix 48

    Abbreviations 48

    Definitions 48

    Research Methodology 49

    Secondary Research 49

    About GlobalData 50

    Contact Us 50

    Disclaimer 50

    Source 51

List Of Tables
in Lysosomal Storage Disorder Global Clinical Trials Review, H2, 2015

List of Tables

Lysosomal Storage Disorder Therapeutics, Global, Clinical Trials by Region, 2015* 6

Lysosomal Storage Disorder Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Lysosomal Storage Disorder Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Lysosomal Storage Disorder Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10

Lysosomal Storage Disorder Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Lysosomal Storage Disorder Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Lysosomal Storage Disorder Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13

Lysosomal Storage Disorder Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14

Proportion of Lysosomal Storage Disorder to Metabolic Disorders Clinical Trials, G7 Countries (%), 2015* 15

Lysosomal Storage Disorder Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Lysosomal Storage Disorder Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Lysosomal Storage Disorder to Metabolic Disorders Clinical Trials, E7 Countries (%), 2015* 18

Lysosomal Storage Disorder Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Lysosomal Storage Disorder Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Lysosomal Storage Disorder Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Lysosomal Storage Disorder Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Lysosomal Storage Disorder Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Lysosomal Storage Disorder Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Lysosomal Storage Disorder Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25

Lysosomal Storage Disorder Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 26

Lysosomal Storage Disorder Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27

Lysosomal Storage Disorder Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29

Lysosomal Storage Disorder Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

List Of Figures, Charts and Diagrams
in Lysosomal Storage Disorder Global Clinical Trials Review, H2, 2015

List of Figures

Lysosomal Storage Disorder Therapeutics, Global, Clinical Trials by Region (%), 2015* 6

Lysosomal Storage Disorder Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7

Lysosomal Storage Disorder Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Lysosomal Storage Disorder Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10

Lysosomal Storage Disorder Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Lysosomal Storage Disorder Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Lysosomal Storage Disorder Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13

Lysosomal Storage Disorder Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14

Proportion of Lysosomal Storage Disorder to Metabolic Disorders Clinical Trials, G7 Countries (%), 2015* 15

Lysosomal Storage Disorder Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Lysosomal Storage Disorder Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Lysosomal Storage Disorder to Metabolic Disorders Clinical Trials, E7 Countries (%), 2015* 18

Lysosomal Storage Disorder Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Lysosomal Storage Disorder Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Lysosomal Storage Disorder Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Lysosomal Storage Disorder Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Lysosomal Storage Disorder Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Lysosomal Storage Disorder Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Lysosomal Storage Disorder Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25

Lysosomal Storage Disorder Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 26

Lysosomal Storage Disorder Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27

Lysosomal Storage Disorder Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28

Lysosomal Storage Disorder Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

GlobalData Methodology 49

Additional Details

Publisher

Global Data

Publisher Information

Reference

17905 | GDHC3148CTIDB

Number of Pages

51

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Global Lysosomal Storage Disease Partnering 2010-2017
The Global Lysosomal Storage Disease Partnering Terms and Agreements since 2010 report provides unde...
01 Nov 2017 by Current Partnering USD $1,495 More Info
Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) - Pipeline Review, H2 2017
Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) - Pipeline Rev...
31 Oct 2017 by Global Markets Direct USD $3,500 More Info
Global Lysosomal Storage Disease Partnering 2010-2017
The Global Lysosomal Storage Disease Partnering Terms and Agreements since 2010 report provides unde...
01 Oct 2017 by Current Partnering USD $1,495 More Info
Global Lysosomal Storage Disease Partnering 2010-2017
The Global Lysosomal Storage Disease Partnering Terms and Agreements since 2010 report provides unde...
01 Sep 2017 by Current Partnering USD $1,495 More Info
Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) - Pipeline Review, H1 2017
Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) - Pipeline Rev...
30 May 2017 by Global Markets Direct USD $3,500 More Info
Lysosomal Storage Disorder-Pipeline Insights, 2017
DelveInsight’s, “ Lysosomal Storage Disorder-Pipeline Insights, 2017”, report provides in depth insi...
30 May 2017 by Delve Insight USD $1,250 More Info
Global Lysosomal Storage Disease Partnering 2010-2017
The Global Lysosomal Storage Disease Partnering Terms and Agreements since 2010 report provides unde...
01 Apr 2017 by Current Partnering USD $1,495 More Info
Global Lysosomal Storage Disease Partnering 2010-2017
The Global Lysosomal Storage Disease Partnering Terms and Agreements since 2010 report provides unde...
01 Feb 2017 by Current Partnering USD $1,495 More Info
Global Lysosomal Storage Disease Partnering 2010-2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Nov 2016 by Current Partnering USD $1,495 More Info
Global Lysosomal Storage Disease Partnering 2010-2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,495 More Info

This report is published by Global Data

Download Free Report Summary PDF

Lysosomal Storage Disorder Global Clinical Trials Review, H2, 2015 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...